GENE ONLINE|News &
Opinion
Blog

China
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Experts Discuss What’s Next for Healthcare Innovation and Investment at ASGH
2021-12-02
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
After Raising $300 Million, China’s Abogen Hunkers Down on mRNA Covid-19 Vaccine with GenScript and Walvax
2021-12-01
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
SK Biopharm Spinout Launches with $180 Million to Bring Neuroscience Drugs to China
2021-11-12
I-Mab Inks $315 Million Pact with Jumpcan to Market Human Growth Hormone in China
2021-11-11
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
China’s Metabolic Drugmaker Scores $70M Series C to Accelerate Drug Trials
2021-10-13
Innovent to Send the First-Ever SIRPa Targeting Antibody to Human Trials in China
2021-09-10
JW Therapeutics’ CAR-T Approval in China Comes On the Heels of its Rival
2021-09-08
China’s Sinopharm to Develop its First mRNA COVID-19 Vaccine
2021-09-07
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
1 2 3 4 5 6 8
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top